Efficacy of antimalarial chemoprophylaxis among French residents travelling to Africa.

@article{Fontanet2005EfficacyOA,
  title={Efficacy of antimalarial chemoprophylaxis among French residents travelling to Africa.},
  author={A Fontanet and Sandrine Houz{\'e} and Annick Keundjian and Ricarda Schiemann and Pascal Ralaimazava and R{\'e}my Durand and Olivier Cha and J. Coulaud and Jacques Le bras and Olivier Bouchaud},
  journal={Transactions of the Royal Society of Tropical Medicine and Hygiene},
  year={2005},
  volume={99 2},
  pages={91-100}
}
Controversy exists about which antimalarial chemoprophylaxis regimen should be used among travellers to Africa: the WHO and other experts recommend the use of mefloquine throughout sub-Saharan Africa, whereas French experts still support the combination of chloroquine and proguanil in most of West Africa (the so-called zone 2 countries). In this case-control study based at a travel clinic, we examined the compliance with antimalarial chemoprophylaxis and its efficacy among travellers to… CONTINUE READING